Cargando…
Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty
PURPOSE: Long-acting gonadotropin-releasing hormone agonists (GnRHa) are commonly used to treat central precocious puberty (CPP) in Korea. Although rare, there have been reports on the characteristic of adverse reactions of GnRHa in CPP among the Korean population. This study was intended to report...
Autores principales: | Lee, Ji Woo, Kim, Hyung Jin, Choe, Yun Mee, Kang, Hee Suk, Kim, Soon Ki, Jun, Yong Hoon, Lee, Ji Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pediatric Endocrinology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208261/ https://www.ncbi.nlm.nih.gov/pubmed/25346917 http://dx.doi.org/10.6065/apem.2014.19.3.135 |
Ejemplares similares
-
Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
por: Kim, Han Kyul, et al.
Publicado: (2011) -
Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty
por: Kwon, Eun Byul, et al.
Publicado: (2015) -
The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
por: Yoon, Jong Wan, et al.
Publicado: (2017) -
Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty
por: Shim, Young Suk, et al.
Publicado: (2020) -
Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
por: Kim, Hye Ryun, et al.
Publicado: (2017)